Egetis Therapeutics AB (LTS:0ABW) Preferred Dividends: kr0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0ABW Egetis Therapeutics AB LTS:0ABW
61 GF Score
Price kr6.82
GF Value kr5.67
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Egetis Therapeutics AB Preferred Dividends?

Egetis Therapeutics AB LTS:0ABW +0.66% 61 Preferred Dividends is kr0.00 Mil as of Mar. 2026. GuruFocus rates LTS:0ABW with a GF Score™ of 61/100 and a GF Value™ of kr5.67 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Egetis Therapeutics AB's preferred dividends for the three months ended in Mar. 2026 was kr0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.00 Mil.

Egetis Therapeutics AB  (LTS:0ABW) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egetis Therapeutics AB Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Egetis Therapeutics AB's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egetis Therapeutics AB Preferred Dividends Chart

Egetis Therapeutics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Egetis Therapeutics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0ABW
61GF Score
Egetis Therapeutics AB LTS:0ABW
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Egetis Therapeutics AB Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of kr0.00 Mil mean?
Egetis Therapeutics AB (LTS:0ABW) has a Preferred Dividends of kr0.00 Mil as of Mar. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Egetis Therapeutics AB and its competitors.
Is Egetis Therapeutics AB's Preferred Dividends too high?
Egetis Therapeutics AB's current Preferred Dividends is kr0.00 Mil. Overall, Egetis Therapeutics AB has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Egetis Therapeutics AB's Preferred Dividends compare to VRTX and REGN?
Egetis Therapeutics AB's Preferred Dividends of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Biotechnology company?
A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Egetis Therapeutics AB and its competitors. Egetis Therapeutics AB's current Preferred Dividends is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egetis Therapeutics AB stock overvalued right now?
Based on GuruFocus' analysis, Egetis Therapeutics AB (LTS:0ABW) is currently considered Modestly Overvalued. The stock's GF Value™ is kr5.67, compared to a current price of kr6.82 — trading 20.3% above its estimated fair value. The current Preferred Dividends is kr0.00 Mil. Egetis Therapeutics AB's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Egetis Therapeutics AB (LTS:0ABW), the current Preferred Dividends is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Egetis Therapeutics AB (LTS:0ABW) Overvalued in 2026?

Based on GuruFocus' analysis, Egetis Therapeutics AB stock appears to be overvalued. The current stock price of kr6.82 is trading 20.3% above its estimated GF Value™ of kr5.67. GuruFocus considers Egetis Therapeutics AB to be Modestly Overvalued.

Key valuation signals for LTS:0ABW:

  • Preferred Dividends: kr0.00 Mil
  • GF Value™: kr5.67 vs. price of kr6.82 (20.3% above fair value)
  • GF Score™: 61/100 with 8 warning signs

No single metric tells the full story. See the LTS:0ABW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Egetis Therapeutics AB Business Description

Address Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.
61GF Score

Get the complete analysis for LTS:0ABW

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.82
Price
kr5.67
GF Value